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and accepted TRUSP Bx were included. The age of the patients, pre-biopsy
serum PSA level, numbers of biopsy cores and pathologic ﬁndings were
recorded and analysed.
Results: The mean age was 83 y/o. Mean pre-biopsy serum PSA was
158.66 ng/ml. The average biopsy cores in each lobe of prostate was 6. The
pathologic segments in each lobe of prostate was 7. Cancer segment's
portion in right and left lobe was 65% and 63%. Gleason score in both lobes
was 8. More than 80% cases was detected prostate adenocarcinoma.
Conclusion: In the group of more than 80 y/o with higher PSA or DRE
ﬁnding, the pathologic ﬁnding revealed the high prevalence of prostate
adenocarcinoma. But these patient are too old to accept radical prosta-
tectomy.We should includemore cases to conﬁrm and adjust the guideline
to match our Taiwanese.
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University, Taipei, TaiwanPurpose: Early detection of prostate guideline from American Urological
Association (AUA) in 2013 does not recommend routine prostatic speciﬁc
antigen (PSA) screening in men younger than 55 year-old at average risk.
The purpose of this study is to investigate the characteristics of TRUS bi-
opsy for patients younger than age of 55, in a hope to assess the beneﬁt of
TRUS biopsy and the occurrence of prostate cancer in this population.
Materials andMethods: Based on retrospective medical records, 812male
patients who received TRUS biopsy during December 2007 to December
2014 at Zhongxiao Branch of Taipei City Hospital were included. Of them,
57 men (7%) were younger than ﬁfty ﬁve year-old. We compare the age,
pre-biopsy, PSA, prostate size, and adenoma size between prostate cancer
group and benign prostatic hyperplasia group.
Results: In these 57 men, 6 of them (10.5%) had prostate cancer (group A),
and 51 men had benign prostatic hyperplasia (group B). The average age of
the group A and B was 51.0± 3.7 and 50.8± 3.1 year-old (P¼0.23). The
mean PSA of group A and B was 15.3± 12.3 and 7.2± 4.5 ng/ml (P<0.05).
The mean prostate size of group A and B was 23.3± 6.1 and 33.6± 14.8 ml
(P¼0.04). The mean adenoma size of group A and B was 8.7± 3.0 and
10.3± 5.5 ml (P¼0.12).
Conclusion: Among selected male patients younger than age of 55, TRUS
biopsy was with a positive detection rate of 10%, and prostate cancer may
be detected in patients with higher level PSA and smaller prostate size.
